Cargando…
Chemogenomic profiling predicts antifungal synergies
Chemotherapies, HIV infections, and treatments to block organ transplant rejection are creating a population of immunocompromised individuals at serious risk of systemic fungal infections. Since single-agent therapies are susceptible to failure due to either inherent or acquired resistance, alternat...
Autores principales: | Jansen, Gregor, Lee, Anna Y, Epp, Elias, Fredette, Amélie, Surprenant, Jamie, Harcus, Doreen, Scott, Michelle, Tan, Elaine, Nishimura, Tamiko, Whiteway, Malcolm, Hallett, Michael, Thomas, David Y |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824495/ https://www.ncbi.nlm.nih.gov/pubmed/20029371 http://dx.doi.org/10.1038/msb.2009.95 |
Ejemplares similares
-
Systematic Prediction of Antifungal Drug Synergy by Chemogenomic Screening in Saccharomyces cerevisiae
por: Gaikani, Hamid, et al.
Publicado: (2021) -
Reverse Genetics in Candida albicans Predicts ARF Cycling Is Essential for Drug Resistance and Virulence
por: Epp, Elias, et al.
Publicado: (2010) -
Chemogenomic Profiling of the Fungal Pathogen Candida albicans
por: Chen, Yaolin, et al.
Publicado: (2018) -
Chemogenomic profiling to understand the antifungal action of a bioactive aurone compound
por: Alqahtani, Fatmah M., et al.
Publicado: (2019) -
Chemogenomic profiling in yeast reveals antifungal mode-of-action of polyene macrolactam auroramycin
por: Wong, Jin Huei, et al.
Publicado: (2019)